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Background: Maternal Smoking During Pregnancy (SDP) has consistently been associated with increased risk of
attention-deficit/hyperactivity disorder (ADHD) in offspring, but recent studies indicate that this association might
be due to unmeasured familial confounding. Methods: A total of 813,030 individuals born in Sweden between 1992
and 2000 were included in this nationwide population-based cohort study. Data on maternal SDP and ADHD
diagnosis were obtained from national registers and patients were followed up from the age of 3 to the end of 2009.
Hazard Ratios (HRs) were estimated using stratified Cox regression models. Cousin and sibling data were used to
control for unmeasured familial confounding. Results: At the population level maternal SDP predicted ADHD in
offspring (HRModerateSDP = 1.89; HRHighSDP = 2.50). This estimate gradually attenuated toward the null when
adjusting for measured confounders (HRModerateSDP = 1.62; HRHighSDP = 2.04), unmeasured confounders shared
within the extended family (i.e., cousin comparison) (HRModerateSDP = 1.45; HRHighSDP = 1.69), and unmeasured
confounders within the nuclear family (i.e., sibling comparison) (HRModerateSDP = 0.88; HRHighSDP = 0.84).
Conclusions: Our results suggest that the association between maternal SDP and offspring ADHD are due to
unmeasured familial confounding. Keywords: Maternal smoking during pregnancy, attention-deficit/hyperactivity
disorder, confounding, sibling comparisons.
Introduction
Attention-Deficit/Hyperactivity Disorder (ADHD),
characterized by impairing symptoms of hyperactiv-
ity, impulsivity and inattention, is a highly prevalent
neuropsychiatric disorder that persists into adult-
hood in a sizable number of affected children of both
genders (Biederman, 2005). In addition to a strong
genetic predisposition to ADHD, environmental fac-
tors account for an estimated 10%–40% of the
variance in liability to the disorder (Banerjee, Mid-
dleton, & Faraone, 2007). Maternal lifestyle factors
during pregnancy, such as stress, alcohol use, and
cigarette smoking may represent environmental risk
factors for ADHD in offspring (Thapar, Cooper, Eyre,
& Langley, 2012), but the mechanisms through
which such risks influence ADHD is poorly under-
stood.
Studies have shown that prenatal exposure to
maternal Smoking During Pregnancy (SDP) is asso-
ciated with low birthweight and preterm birth (Cnat-
tingius, 2004) and also suggest plausible biological
mechanisms through which SDP may influence
brain development, including deleterious effects on
neurotransmission, neuronal differentiation, and
migration (Dwyer, McQuown, & Leslie, 2009; Slot-
kin, Tate, Cousins, & Seidler, 2006). A robust
association between SDP and ADHD in offspring
has been observed in previous epidemiological stud-
ies, even after adjustment for measured confounders
(Banerjee et al., 2007; Langley, Rice, van den Bree, &
Thapar, 2005; Linnet et al., 2003; Motlagh et al.,
2010; Rodriguez & Bohlin, 2005) suggesting possible
causality. Other researchers express great skepti-
cism, however, because of the inability of these
studies to rule out unmeasured familial factors
(Knopik, 2009; Thapar & Rutter, 2009). For
instance, the heritability of both SDP (Agrawal et al.,
2008; D’Onofrio et al., 2003; Ellingson, Rickert,
Lichtenstein, Langstrom, & D’Onofrio, 2012) and
ADHD (Larsson, Anckarsater, Rastam, Chang, &
Lichtenstein, 2012), as well as the recent reports of a
genetic overlap between ADHD and smoking (August
et al., 2006; Chang, Lichtenstein, & Larsson, 2012;
Monuteaux et al., 2008), indicate that maternal SDP
may reflect a genetic predisposition rather than a
causal risk factor for offspring ADHD. As randomized
controlled trials are impossible, quasi-experimental
designs (e.g., sibling and cousin comparison analy-
ses) are needed to rule out unmeasured familial
factors (Rutter, 2009).
Available evidence from studies using different
quasi-experimental designs including one study of
SDP in both mothers and fathers (Langley, Heron,
Smith, & Thapar, 2012), one in vitro cross-fostering
study (Thapar et al., 2009), and three sibling com-
parison studies (D’Onofrio et al., 2008; Lindblad &
Hjern, 2010; Obel et al., 2011) suggest that theConflict of interest statement: No conflicts declared.
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dose-dependent relationship between SDP and
offspring ADHD is due to unmeasured familial
factors (i.e., genetic and/or household-level factors).
However, these previous quasi-experimental studies
of ADHD have noteworthy limitations. First, studies
comparing the offspring ADHD risk between mater-
nal and paternal SDP have produced mixed results
and are limited by small sample sizes (Langley et al.,
2012; Nomura, Marks, & Halperin, 2010). Second,
using children who remain unrelated to their moth-
ers through assisted conception to study SDP is a
novel approach for disentangling genetic confounds
from prenatal risks, but the findings for SDP and
ADHD need to be replicated, as the results were
based on parent-rated ADHD symptoms during
childhood from a small study of children conceived
through assisted reproductive technologies (Thapar
et al., 2009). Third, previous sibling studies have
been limited by imprecise risk estimates (because of
small sample sizes) and by inadequate proxy mea-
sures, including use of ADHD medication during
only one calendar year (Lindblad & Hjern, 2010) and
maternal ratings of ADHD-related problems (D’On-
ofrio et al., 2008). In addition, previous sibling
studies were not able to identify and exclude
half-siblings which mean that the effect of familial
confounding may have been underestimated (D’On-
ofrio et al., 2008; Obel et al., 2011). Clearly, addi-
tional quasi-experimental research is needed to
address these limitations.
Using a large population-based cohort of children,
we tested the hypothesis that maternal SDP is a
causal risk factor for offspring ADHD. To explicitly
address concerns about the generalizability of the
findings from previous sibling comparison studies
(Talati & Weissman, 2010) and limitations inherent
in the design (e.g., women who vary in their smoking
status are different from those that smoke across
pregnancies) (D’Onofrio, Lahey, Turkheimer, & Lich-
tenstein, 2013) the current study also included
cousin comparisons. We explored the impact of
confounding factors by (a) controlling for measured
covariates, (b) comparing full cousins (offspring of
adult full siblings) within extended families to con-
trol for all unmeasured factors that make cousins
similar, and (c) comparing full siblings within
nuclear families to control for all unmeasured factors
that make siblings similar.
Method
Sample
Data sources. We utilized data from a record
linkage of eight population-based registries in Swe-
den; personal identification numbers enabled accu-
rate linkage.
The population-based Medical Birth Register
(MBR) provides information on SDP in Sweden since
1983 through self-reported prospective information
at the registration to antenatal care (in pregnancy
week 8–12). Swedish maternal health care has a
national homogenous structure and reaches almost
99% of all Swedish women before pregnancy week 15
(Lindmark & Cnattingius, 1991). The Patient Regis-
ter (PR) provides data on psychiatric inpatient care
since 1987 (ICD-9 to ICD-10) and outpatient care
(ICD-10) since 2001. The Swedish Prescribed Drug
register (PDR) (Wettermark et al., 2007) contain
information on drug identity (Anatomical Therapeu-
tic Chemical [ATC-codes]) and dates of all registered
prescriptions to the entire population in Sweden
since July 2005. The Multigeneration Register (MGR)
contain information on the identity of the parents of
all residents born in Sweden since 1932. The Cause
of Death Register (CDR) provides information on
dates of all registered deaths since 1958. The Migra-
tion Register (MR) includes information on dates of
all registered migrations into or out of Sweden since
1969. The LISA Register contains information on
education, employment, and income of individuals in
each household in Sweden at the end of 2009. The
Stockholm Children and Adolescents Psychiatric
Care Register (Pastill) cover information on psychi-
atric diagnoses based on both ICD-10 and Diagnostic
and Statistical Manual of Mental Disorders (DSM-IV)
for all children and adolescents living in Stockholm
County since 2001. The study was approved by the
research ethics committee at Karolinska Institute,
Stockholm, Sweden Protocol nr 2009/5:9.
Study population. After identification of all indi-
viduals born in Sweden between 1992 and 2000
(N = 894,444) and exclusion of individuals with
serious congenital malformations (N = 32,209), mul-
tiple births (N = 25,302), still born before or during
delivery (N = 2,767), dead before 3 years of age or
before 2001(N = 2,613), emigrated before 3 years of
age or before 2001 (N = 18,226), missing data on
mother’s identification number (n = 250) or who had
received an ADHD diagnosis before 3 years of age
(n = 47), an eligible sample of 813,030 individuals
(90.90% of the targeted population) was identified
from MBR (Figure 1). After exclusion due to missing
values on SDP (N = 44,803) the study population
included 768,227 individuals covering 365,442 full
siblings nested within 172,701 families and 155,852
cousins nested within 52,183 families. All the
individuals were followed up from the age of 3
until diagnosis of ADHD, death, emigration, or 31
December 2009, whichever occurred first.
Measures
Offspring Outcomes. We identified 13,996 patients
with an in- or outpatient diagnosis of Hyperkinetic
Disorder (HKD) (F90 in ICD-10) between January
2001 and December 2009 from PR, and 3,352
patients with diagnoses of HKD (F90 in ICD-10) or
ADHD (DSM-IV:314) from Pastill. A total of 16,216
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patients treated with stimulant or nonstimulant
medication for ADHD (methylphenidate [N06BA04];
atomoxetin [N06BA09]; amphetamine [N06BA01];
dexamphetamine [N06BA02]) at any time between
July 2005 and December 2009 were identified via
the PDR. Altogether 19,891 unique ADHD cases
were identified after adjustment of overlaps between
the three registers. According to Swedish national
clinical guidelines, issued by The National Board of
Health and Welfare, ADHD or HKD should be diag-
nosed by a specialist psychiatrist after a clinical
somatic and psychiatric evaluation including child-
hood history, somatic evaluation, and cognitive
assessments by a child psychologist. ADHD and
HKD diagnoses in PR as well as in Pastill are based
on DSM-IV and/or ICD-10 criteria. We used data
from 19,150 twins (born between 1992 and 2001)
with psychiatric symptom information from the
Swedish Twin Registry to check the validity of the
register-based ADHD diagnosis. ADHD symptoms
were assessed using a well-validated measure of 96
specific child psychiatric symptoms (Hansson et al.,
2005; Larson et al., 2010). About 70% of the twins
with a national register-based ADHD diagnosis
recorded in the National Patient Register were also
rated as screen positive by parents (Larsson et al.,
2013). Because it is well established that discrepan-
cies often exist among different raters (e.g., parents,
children, physicians, and psychologists) (De Los
Reyes & Kazdin, 2005), the high overlap between
different informants suggest that the national regis-
ter-based diagnoses of ADHD are valid.
Exposure. SDP was measured on a 3-point scale
(No SDP = 0, moderate SDP = 1–9, or high
SDP = ≥10 cigarettes per day). The measure has
been validated using numerous outcome measures,
and has shown to be highly correlated with serum
cotinine levels (Lindqvist, Lendahls, Tollbom, Aberg,
& Hakansson, 2002). Previous studies have shown
that the validity of self-reported smoking has not
changed over time and also acceptable validity of
self-reported smoking habits when compared with
biochemical markers (measured levels of cotinine in
blood) (Hatziandreu et al., 1989).
Covariates. Based on previous research (D’Onof-
rio, Singh, Iliadou, Lambe, Hultman, Grann et al.,
2010; D’Onofrio, Singh, Iliadou, Lambe, Hultman,
Neiderhiser et al., 2010; Lundberg et al., 2010),
measured covariates included sex, birth year
(1992–1994, 1995–1997, and 1998–2000), mother′
s parity (1st, 2nd, 3rd, or ≥4th), maternal age at
childbirth (≤19, 20–24, 25–29, 30–34, or ≥35 years),
cohabitation with offspring’s father (yes or no),
maternal highest education (≤9 years, 10–12 years
or graduation education), and mother’s country of
birth (Sweden, other Scandinavian countries or
others). As low birthweight might be an intermediate
factor of the association between SDP and ADHD, we
All individuals born in Sweden between
1992 and 2000 (N = 894 444)
Congenital malformation (N = 32 209)
Multiple births N = (25 302)
Stillbirth  (N = 2 767)
Death before 3 years of age or before the year of
2001 (N = 2 613)
Emigration before 3 years of age or before the
year of 2001 (N = 18 226)
Missing for mother’s ID (N = 250) 
Receiving ADHD diagnosis before the age of 3
 (N = 47)
Eligible Population (N = 813 030)
Study Population (N = 768 227), including
19 891 ADHD cases
Missing for smoking during pregnancy (N = 44 803,
5.51% of the eligible population)
Figure 1 Sample selection
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choose not to adjust for that measure. Prepregnancy
BMI is considered partly adjusted for by maternal
education level and could potentially be an interme-
diate factor, thus not included as a covariate in the
model.
Statistical analyses
We used Cox proportional survival analysis to esti-
mate the magnitude of the associations between SDP
and offspring ADHD at the population level. The
models calculated Hazard ratios (HRs) for time to
ADHD diagnosis. Robust standard errors adjusted
the 95% confidence intervals (CIs) for the presence of
familial clustering in the analyses at the population
level. In addition to a crude model, we also adjusted
for the above-mentioned measured covariates.
To explore the effect of unmeasured familial con-
founding, we applied stratified Cox regression mod-
els to cousin and sibling data with a separate stratum
for each set of full cousins and siblings, respectively.
In the cousin sample, 41,028 cousins nested in
13,372 extended families were discordantly exposed
to SDP, whereas in the sibling sample, there were
26,826 discordantly exposed siblings nested in
12,507 nuclear families. Cousin comparisons adjust
for all unmeasured factors that are constant within
the extended family, whereas the sibling compari-
sons adjust for factors that are constant within the
nuclear family. The stratified Cox regression models
using cousins were adjusted for the same covariates
as in the models at the population level. The regres-
sion models applied to siblings were not adjusted for
maternal highest education and mother’s country of
birth, as these were regarded constant or unlikely to
change within siblings.
We conducted sensitivity analyses to assess the
potential modifying effect of birth order on the
studied associations. We also analyzed a birth year
restricted sibling cohort to explore potential bias
from outcome misclassification. Furthermore, we
explored the generalizability of our results by com-
paring the sibling sample to the entire cohort (D’On-
ofrio et al., 2013). All statistical analyses were
conducted in SAS software version 9.3 (SAS Insti-
tute, Cary, NC, USA).
Results
Table 1 shows the distribution of offspring and
maternal covariates. Offspring exposed to maternal
SDP were more likely to be of late parity (p < .0001),
have mothers with lower education (p < .01), and
their mothers were less likely to cohabit with their
biological father at childbirth.
In Table 2, the crude association showed that
offspring exposed to maternal SDP were at increased
risk for ADHD (HRModerateSDP 1.89; HRHighSDP 2.50).
This dose-dependent association decreased margin-
ally after adjustment for measured covariates and
remained statistically significant (HRModerateSDP
1.62; HRHighSDP 2.04). The associations were further
attenuated in the cousin comparisons; that is, after
adjustment for all unmeasured factors that are
constant within extended families (HRModerateSDP
1.45; HRHighSDP 1.69). Sibling comparisons showed
that the associations observed at the population level
were completely attenuated and no longer statisti-
cally significant (HRModerateSDP 0.88; HRHighSDP 0.84),
indicating that unmeasured familial factors that are
constant within nuclear families explain the associ-
ations.
Sensitivity analyses
Sensitivity analyses were conducted to explore
assumptions and to test the robustness of the
findings.
Second-born offspring were more often exposed to
maternal SDP than first-born offspring. Therefore,
we used another sibling sample including only first-
and second-born offspring (N = 345,402) from each
nuclear family to test the modifying effect of
birth order on the studied association. Stratified
analyses at the population level showed similar
results for first-born and second-born siblings
(HRModerateSDP_FirstBorn 1.62 95% CI, 1.49–1.76;
HRHighSDP_FirstBorn 1.95 95% CI, 1.76–2.16;
HRModerateSDP_SecondBorn 1.58 95% CI, 1.42–1.75;
and HRHighSDP_SecondBorn 2.13 95% CI, 1.90–2.39).
Because the outpatient register (started in 2001)
and PDR (started in 2005) are relatively new, we
explored potential bias from outcome misclassifica-
tion. For instance, older siblings with an ADHD
diagnosis early in life may not have been recorded
with a diagnosis in this register. To minimize this
potential bias, we performed a separate sibling
comparison within a restricted cohort of offspring
born 1994–1998. The two siblings from each nuclear
family who were closest in age were selected for
sibling comparisons, resulting in 123,974 full
siblings nested within 61,987 families (the average
age difference between siblings was 2.34 years).
The results from the restricted sibling sample
(HRModerateSDP, 1.01; 95% CI, 0.73–1.41; HRHighSDP
1.08; 95% CI, 0.70–1.66) were similar to that
observed in the full sibling sample.
Finally, we explored the generalizability of the
results from siblings to the entire cohort. We ana-
lyzed siblings as unrelated individuals using robust
standard errors and the results in the sibling sample
(HRModerateSDP, 1.62; 95% CI, 1.51–1.73; HRHighSDP
2.06; 95% CI, 1.90–2.22) were very similar to that in
the entire cohort (HRModerateSDP, 1.62; 95% CI, 1.56–
1.69; HRHighSDP 2.04; 95% CI, 1.95–2.13).
Discussion
In this population-based cohort study, we used two
different quasi-experimental designs (i.e., cousin
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and sibling comparisons) to explore the mechanisms
through which maternal SDP influence ADHD. Our
results suggest that the association between mater-
nal SDP and offspring ADHD can be ascribed to
unmeasured familial confounding. Similar results
have been reported in quasi-experimental studies of
ADHD from Finland (Obel et al., 2011), United
Kingdom (Langley et al., 2012; Thapar et al., 2009),
and the United States (D’Onofrio et al., 2008), indi-
cating that the study results generalize across sam-
ples with different demographic, racial, or ethnic
characteristics. These results are also consistent
with quasi-experimental studies of SDP for
ADHD-related outcomes, such as disruptive behav-
iors, criminality, and academic/cognitive problems
(D’Onofrio et al., 2013).
Table 2 Relative risks of ADHD among offspring exposed to smoking during pregnancy
Exposure
HR (95% CI)
Crudea Adjustedb Cousinsc Full siblingd
No SDP Reference Reference Reference Reference
Moderate SDP (1–9 cigarettes per day) 1.89 (1.83–1.97) 1.62 (1.56–1.69) 1.45 (1.24–1.68) 0.88 (0.73–1.06)
High SDP (≥10 cigarettes per day) 2.50 (2.40–2.61) 2.04 (1.95–2.13) 1.69 (1.40–2.04) 0.84 (0.65–1.06)
aN = 768,227.
bN = 720,853 Adjusted for offspring gender, birth year, mother’s parity, maternal age, cohabitation status, maternal highest
education, and mother’s country of birth.
cN = 155,852 Adjusted for offspring gender, birth year, mother’s parity, maternal age, and cohabitation status.
dN = 365,442 Adjusted for offspring gender, birth year, mother’s parity, maternal age, and cohabitation status.
Table 1 Demographic characteristics of mothers and offspring
Entire cohorta (N = 768,227) Cousinsb (N = 155,852) Full siblingsc (N = 365,442)
Covariates [N (%)] [N (%)] [N (%)]
SDP
No cigarette 638,400 (83.1) 129,362 (83.0) 317,836 (87.0)
1–9 cigarettes per day 83,830 (10.9) 16,991 (10.9) 31,321 (8.6)
≥10 cigarettes per day 45,997 (6.0) 9,499 (6.1) 16,282 (4.5)
Sex
Male 392,865 (51.1) 79,688 (51.1) 187,460 (51.3)
Female 375,282 (48.9) 76,164 (48.9) 177,982 (48.7)
Birth year
1992–1994 301,273 (39.2) 60,917 (39.1) 124,104 (34.0)
1995–1997 247,989 (32.3) 51,532 (33.1) 142,840 (39.1)
1998–2000 218,965 (28.5) 43,403 (27.8) 98,498 (27.0)
Mother’s parity
1st 314,257 (40.9) 60,719 (39.0) 133,153 (36.4)
2nd 284,924 (37.1) 59,325 (38.1) 157,804 (43.2)
3rd 116,842 (15.2) 25,300 (16.2) 50,570 (13.8)
≥4th 52,187 (6.8) 10,508 (6.7) 23,915 (6.5)
Maternal age at childbirth (years)
≤19 11,282 (1.5) 1,752 (1.1) 3,621 (0.99)
20–24 120,223 (15.6) 23,964 (15.4) 60,434 (16.5)
25–29 278,200 (36.2) 60,992 (39.1) 144,326 (39.5)
30–34 238,729 (31.1) 50,053 (32.1) 113,786 (31.0)
≥35 119,793 (15.6) 19,091 (12.3) 43,275 (11.8)
Cohabit with offspring’s father
Yes 697,508 (94.9) 148,971 (95.6) 355,678 (97.3)
No 37,309 (5.1) 6,881 (4.4) 9,768 (2.7)
Maternal highest education
≤9 years 73,484 (9.8) 12,440 (8.0) 31,136 (8.7)
10–12 years 381,133 (50.6) 81,879 (52.5) 178,615 (49.8)
Graduate education 298,949 (39.7) 61,533 (39.5) 149,295 (41.6)
Mother’s country of birth
Sweden 647,746 (84.3) 148,511 (95.3) 310,254 (84.9)
Denmark, Finland, Norway, or Iceland 20,626 (2.7) 2,603 (1.7) 8,332 (2.3)
Other 99,837 (13.0) 4,738 (3.0) 46,851 (12.8)
aIn the entire cohort 80 individuals were missing data for sex, 17 for mother’s parity, 1 for maternal age at delivery, 33,410 for
cohabitation status, 14,661 for maternal highest education, and 18 for mother’s country of birth.
bCousins with missing values on any of the above-mentioned covariates were precluded.
cIn the full sibling sample, 6,396 individuals were missing data on education and 5 for mother’s country of birth.
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Our study addresses four critical limitations of
previous sibling comparison studies (D’Onofrio
et al., 2008; Lindblad & Hjern, 2010; Obel et al.,
2011). First, our study was based on more than twice
as many ADHD cases compared with the previous
register-based sibling studies (Lindblad & Hjern,
2010; Obel et al., 2011), which allowed for more
precise estimates (i.e., narrow confidence intervals)
of the magnitude of the associations between SDP
and offspring ADHD, even in the sibling and cousin
comparisons. Second, the prior Swedish regis-
ter-based study identified ADHD cases from medi-
cation use during one calendar year. This may have
introduced bias in the sibling analyses due to
misclassification of discordant and concordant sib-
ling pairs. The large difference in the number of
identified ADHD cases (despite similar N for the
study population) between studies, coupled with
sensitivity analyses based on a restricted cohort of
siblings close in age, indicates that bias from
outcome misclassification is unlikely in our study.
Third, previous studies might be confounded by the
fact that mothers reported on both SDP and offspring
behaviors (D’Onofrio et al., 2008), while we in con-
trast used measured SDP via self-ratings at the first
registration to antenatal care and obtained outcome
information via clinical diagnosis made by physi-
cians.
Finally, the results from previous sibling studies
have been questioned by researchers who have
explicitly hypothesized that women who vary in their
smoking status across pregnancies are not compa-
rable to all smoking women (Frisell, Oberg,
Kuja-Halkola, & Sjolander, 2012). We used cousin
comparisons to overcome the concern of external
validity and observed converging evidence across
different quasi-experimental designs, which further
strengthen the familial confounding hypothesis.
Our results should be interpreted in the context of
some limitations. Although sibling comparison will
not be confounded by factors shared by siblings, the
estimates might theoretically be more sensitive to
bias due to nonshared confounders than the
unpaired estimates (Frisell et al., 2012). The ascer-
tainment of ADHD cases was predominantly based
on ICD-10 diagnosis of hyperkinetic disorder and
prescribed medication unique for the treatment of
ADHD. The ICD-10 definition of ADHD is stricter
compared with that in DSM-IV, and National guide-
lines for medication of ADHD, issued by the Swedish
National Board of health and Welfare in 2002, stated
that medication should be reserved for cases where
other supportive interventions have failed, indicating
that our proxies for ADHD most likely underestimate
the incidence of ADHD and identify severe ADHD
cases. Thus, our strategies probably could not avoid
producing false negatives, while we consider bias
due to false positives more unlikely. It should also be
noted that our findings do not rule out the possibility
of an association between SDP and more refined
ADHD-related neurocognitive deficits, such as exec-
utive function, response inhibition, and fine motor
skills. To further explore this issue, studies using
more detailed and refined outcome measures are
warranted. As in all observational studies, we could
not fully rule out residual confounding due to a lack
of intact information on the exposure variable and
other potential confounders. Also, as SDP was
assessed at the first visit to antenatal care and used
as a proxy for the entire pregnancy, there is a
possibility of misclassification of exposure. In addi-
tion, pregnant women may also conceal their smok-
ing habits (Lindqvist et al., 2002). However, previous
studies have repeatedly shown support for a causal
association between maternal SDP and low birth-
weight suggesting that the effect of exposure mis-
classification is small in magnitude (Cnattingius,
2004; D’Onofrio et al., 2012).
Conclusion
In conclusion, our data suggest that the previously
observed association between maternal SDP and
ADHD can be ascribed to unmeasured familial
confounding. There is mounting evidence that SDP
is harmful in many ways (e.g., low birthweight and
infant mortality) and our results should not be
interpreted as an argument for changing the recom-
mendations that women should not smoke during
pregnancy. Nevertheless, we view our study as a
contribution to the current state of knowledge con-
cerning causal risk factors for ADHD. It is essential
for clinicians, researchers, and policy-makers to
focus on true causal risk factors and SDP is most
probably not one of these.
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Key points
• Maternal smoking during pregnancy is commonly cited in the literature as a risk factor for ADHD in offspring.
• In this nationwide register-based cohort study cousin and sibling data were used to control for unmeasured
familial confounding.
• Our results suggest that the association between maternal smoking during pregnancy and offspring ADHD can
be ascribed to unmeasured familial confounding.
• It is essential for clinicians, researchers, and policy-makers to focus on true causal risk factors, and maternal
smoking during pregnancy is most probably not one of these.
References
Agrawal, A., Knopik, V.S., Pergadia, M.L., Waldron, M.,
Bucholz, K.K., Martin, N.G., … & Madden, P.A. (2008).
Correlates of cigarette smoking during pregnancy and its
genetic and environmental overlap with nicotine
dependence. Nicotine and Tobacco Research, 10, 567–578.
August, G.J., Winters, K.C., Realmuto, G.M., Fahnhorst, T.,
Botzet, A., & Lee, S. (2006). Prospective study of adolescent
drug use among community samples of ADHD and
non-ADHD participants. Journal of the American Academy
of Child and Adolescent Psychiatry, 45, 824–832.
Banerjee, T.D., Middleton, F., & Faraone, S.V. (2007).
Environmental risk factors for attention-deficit
hyperactivity disorder. Acta Paediatrica, 96, 1269–1274.
Biederman, J. (2005). Attention-deficit/hyperactivity disorder:
a selective overview. [Review]. Biological Psychiatry, 57,
1215–1220.
Chang, Z., Lichtenstein, P., & Larsson, H. (2012). The effects of
childhood ADHD symptoms on early-onset substance use: a
Swedish twin study. Journal of Abnormal Child Psychology,
40, 425–435.
Cnattingius, S. (2004). The epidemiology of smoking during
pregnancy: smoking prevalence, maternal characteristics,
and pregnancy outcomes. Nicotine and Tobacco Research, 6
(Suppl 2), S125–S140.
De Los Reyes, A., & Kazdin, A.E. (2005). Informant
discrepancies in the assessment of childhood
psychopathology: a critical review, theoretical framework,
and recommendations for further study. Psychological
Bulletin, 131, 483–509.
D’Onofrio, B.M., Lahey, B. B., Turkheimer, E., & Lichtenstein, P.
(2013). The critical need for family-based, quasi-experimental
research in integrating genetic and social science research.
American Journal of Public Health, in press.
D’Onofrio, B.M., Rickert, M.E., Langstrom, N., Donahue, K.L.,
Coyne, C.A., Larsson, H., … & Lichtenstein, P. (2012).
Familial confounding of the association between maternal
smoking during pregnancy and offspring substance use and
problems. Archives of General Psychiatry, 69, 1140–1150.
D’Onofrio, B.M., Singh, A.L., Iliadou, A., Lambe, M., Hultman,
C.M., Grann, M., … & Lichtenstein, P. (2010). Familial
confounding of the association between maternal smoking
during pregnancy and offspring criminality: a
population-based study in Sweden. Archives of General
Psychiatry, 67, 529–538.
D’Onofrio, B.M., Singh, A.L., Iliadou, A., Lambe, M., Hultman,
C.M., Neiderhiser, J.M., … & Lichtenstein, P. (2010). A
quasi-experimental study of maternal smoking during
pregnancy and offspring academic achievement. Child
Development, 81, 80–100.
D’Onofrio, B.M., Turkheimer, E.N., Eaves, L.J., Corey, L.A.,
Berg, K., Solaas, M.H., & Emery, R.E. (2003). The role of the
children of twins design in elucidating causal relations
between parent characteristics and child outcomes. Journal
of Child Psychology and Psychiatry, 44, 1130–1144.
D’Onofrio, B.M., Van Hulle, C.A., Waldman, I.D., Rodgers, J.L.,
Harden, K.P., Rathouz, P.J., & Lahey, B. (2008). Smoking
during pregnancy and offspring externalizing problems: an
exploration of genetic and environmental confounds.
Development and Psychopathology, 20, 139–164.
Dwyer, J.B., McQuown, S.C., & Leslie, F.M. (2009). The
dynamic effects of nicotine on the developing brain.
Pharmacology and Therapeutics, 122, 125–139.
Ellingson, J.M., Rickert, M.E., Lichtenstein, P., Langstrom, N.,
& D’Onofrio, B.M. (2012). Disentangling the relationships
between maternal smoking during pregnancy and
co-occurring risk factors. Psychological Medicine, 42,
1547–1557.
Frisell, T., Oberg, S., Kuja-Halkola, R., & Sjolander, A. (2012).
Sibling comparison designs: bias from non-shared
confounders and measurement error. Epidemiology, 23,
713–720.
Hansson, S.L., Svanstrom Rojvall, A., Rastam, M., Gillberg, C.,
Gillberg, C., & Anckarsater, H. (2005). Psychiatric telephone
interview with parents for screening of childhood autism –
tics, attention-deficit hyperactivity disorder and other
comorbidities (A-TAC): preliminary reliability and validity.
British Journal of Psychiatry, 187, 262–267.
Hatziandreu, E.J., Pierce, J.P., Fiore, M.C., Grise, V., Novotny,
T.E., & Davis, R.M. (1989). The reliability of self-reported
cigarette consumption in the United States. American
Journal of Public Health, 79, 1020–1023.
Knopik, V.S. (2009). Maternal smoking during pregnancy and
child outcomes: real or spurious effect? Developmental
Neuropsychology, 34, 1–36.
Langley, K., Heron, J., Smith, G.D., & Thapar, A. (2012).
Maternal and paternal smoking during pregnancy and risk
of ADHD symptoms in offspring: testing for intrauterine
effects. American Journal of Epidemiology, 176, 261–268.
Langley, K., Rice, F., van den Bree, M.B., & Thapar, A. (2005).
Maternal smoking during pregnancy as an environmental
risk factor for attention deficit hyperactivity disorder
behaviour. A review. Minerva Pediatrica, 57, 359–371.
Larson, T., Anckarsater, H., Gillberg, C., Stahlberg, O.,
Carlstrom, E., Kadesjo, B., … & Gillberg, C. (2010). The
autism–tics, AD/HD and other comorbidities inventory
(A-TAC): further validation of a telephone interview for
epidemiological research. BMC Psychiatry, 10, 1.
Larsson, H., Anckarsater, H., Rastam, M., Chang, Z., &
Lichtenstein, P. (2012). Childhood attention-deficit
hyperactivity disorder as an extreme of a continuous trait:
a quantitative genetic study of 8,500 twin pairs. Journal of
Child Psychology and Psychiatry, 53, 73–80.
Larsson, H., Ryden, E., Boman, M., Langstrom, N.,
Lichtenstein, P., & Landen, M. (2013). Risk of bipolar
disorder and schizophrenia in relatives of people with
attention-deficit hyperactivity disorder. Br J Psychiatry.
Lindblad, F., & Hjern, A. (2010). ADHD after fetal exposure to
maternal smoking. Nicotine and Tobacco Research, 12, 408–
415.
© 2013 The Authors. Journal of Child Psychology and Psychiatry © 2013 Association for Child and Adolescent Mental Health.
Maternal smoking during pregnancy and ADHD in offspring 7
Lindmark, G., & Cnattingius, S. (1991). The scientific basis of
antenatal care. Report from a state-of-the-art conference.
Acta Obstetricia et Gynecologica Scandinavica, 70, 105–109.
Lindqvist, R., Lendahls, L., Tollbom, O., Aberg, H., &
Hakansson, A. (2002). Smoking during pregnancy:
comparison of self-reports and cotinine levels in 496
women. Acta Obstetricia et Gynecologica Scandinavica, 81,
240–244.
Linnet, K.M., Dalsgaard, S., Obel, C., Wisborg, K., Henriksen,
T.B., Rodriguez, A., … & Jarvelin, M.R. (2003). Maternal
lifestyle factors in pregnancy risk of attention deficit
hyperactivity disorder and associated behaviors: review of
the current evidence. American Journal of Psychiatry, 160,
1028–1040.
Lundberg, F., Cnattingius, S., D’Onofrio, B., Altman, D.,
Lambe, M., Hultman, C., & Iliadou, A. (2010). Maternal
smoking during pregnancy and intellectual performance in
young adult Swedish male offspring. Paediatric and
Perinatal Epidemiology, 24, 79–87.
Monuteaux, M.C., Faraone, S.V., Hammerness, P., Wilens,
T.E., Fraire, M., & Biederman, J. (2008). The familial
association between cigarette smoking and ADHD: a study
of clinically referred girls with and without ADHD, and their
families. Nicotine and Tobacco Research, 10, 1549–1558.
Motlagh, M.G., Katsovich, L., Thompson, N., Lin, H., Kim, Y.S.,
Scahill, L., … & Leckman, J.F. (2010). Severe psychosocial
stress and heavy cigarette smoking during pregnancy: an
examination of the pre- and perinatal risk factors associated
with ADHD and Tourette syndrome. European Child and
Adolescent Psychiatry, 19, 755–764.
Nomura, Y., Marks, D.J., & Halperin, J.M. (2010). Prenatal
exposure to maternal and paternal smoking on attention
deficit hyperactivity disorders symptoms and diagnosis in
offspring. The Journal of Nervous and Mental Disease, 198,
672–678.
Obel, C., Olsen, J., Henriksen, T.B., Rodriguez, A., Jarvelin,
M.R., Moilanen, I., … & Gissler, M. (2011). Is maternal
smoking during pregnancy a risk factor for hyperkinetic
disorder?–Findings from a sibling design. [Research
Support, Non-U.S. Gov’t]. International Journal of
Epidemiology, 40, 338–345.
Rodriguez, A., & Bohlin, G. (2005). Are maternal smoking and
stress during pregnancy related to ADHD symptoms in
children? Journal of Child Psychology and Psychiatry, 46,
246–254.
Rutter, M. (2009). Understanding and testing risk mechanisms
for mental disorders. Journal of Child Psychology and
Psychiatry, 50, 44–52.
Slotkin, T.A., Tate, C.A., Cousins, M.M., & Seidler, F.J. (2006).
Prenatal nicotine exposure alters the responses to
subsequent nicotine administration and withdrawal in
adolescence: serotonin receptors and cell signaling.
Neuropsychopharmacology, 31, 2462–2475.
Talati, A., & Weissman, M.M. (2010). In utero smoking
exposure warrants further investigation. Archives of
General Psychiatry, 67, 1094.
Thapar, A., Cooper, M., Eyre, O., & Langley, K. (2012).
Practitioner Review: what have we learnt about the causes
of ADHD? J Child Psychol Psychiatry, 54, 3–16.
Thapar, A., Rice, F., Hay, D., Boivin, J., Langley, K., van den
Bree, M., … & Harold, M. (2009). Prenatal smoking might
not cause attention-deficit/hyperactivity disorder: evidence
from a novel design. Biological Psychiatry, 66, 722–727.
Thapar, A., & Rutter, M. (2009). Do prenatal risk factors cause
psychiatric disorder? Be wary of causal claims. British
Journal of Psychiatry, 195, 100–101.
Wettermark, B., Hammar, N., Fored, C.M., Leimanis, A.,
Otterblad Olausson, P., Bergman, U., … & Rosen, M.
(2007). The new Swedish Prescribed Drug Register–
opportunities for pharmacoepidemiological research and
experience from the first six months.
Pharmacoepidemiology and Drug Safety, 16, 726–735.
Accepted for publication: 13 June 2013
© 2013 The Authors. Journal of Child Psychology and Psychiatry © 2013 Association for Child and Adolescent Mental Health.
8 Charlotte Skoglund et al.
